Neuromuscular Disorders in Severe Acute Respiratory Syndrome

Abstract

The neuromuscular problems in patients with SARS are considered to be critical-illness polyneuropathy or myopathy, possibly coexistent. Further pathological and microbiological studies are necessary to determine the relationship between SARS coronavirus and neuromuscular problems.

Frequency of Neurological Presentations of Coronavirus Disease in Patients Presenting to a Tertiary Care Hospital During the 2019 Coronavirus Disease Pandemic

“…In comparison, of 214 COVID-19 patients in Wuhan, China, 78 (36.4%) had neurologic manifestation, a much higher percentage [ 2 - 5 ]. Our study confirmed that headache (6%), altered level of consciousness and encephalopathy (2%), hemiparesis (stroke; 0.6%), GBS (0.3%) and seizure (0.3%) were the most frequently reported neurological presentations [ 5 , 6 , 7 , 8 ].…”

“…[2][3][4][5]. Our study confirmed that headache (6%), altered level of consciousness and encephalopathy (2%), hemiparesis (stroke; 0.6%), GBS (0.3%) and seizure (0.3%) were the most frequently reported neurological presentations [5,6,7,8].…”

Frequency of Neurological Presentations of Coronavirus Disease in Patients Presenting to a Tertiary Care Hospital During the 2019 Coronavirus Disease Pandemic

“…In comparison, of 214 COVID-19 patients in Wuhan, China, 78 (36.4%) had neurologic manifestation, a much higher percentage [ 2 - 5 ]. Our study confirmed that headache (6%), altered level of consciousness and encephalopathy (2%), hemiparesis (stroke; 0.6%), GBS (0.3%) and seizure (0.3%) were the most frequently reported neurological presentations [ 5 , 6 , 7 , 8 ].…”

“…[2][3][4][5]. Our study confirmed that headache (6%), altered level of consciousness and encephalopathy (2%), hemiparesis (stroke; 0.6%), GBS (0.3%) and seizure (0.3%) were the most frequently reported neurological presentations [5,6,7,8].…”

Coronaviruses and the Chemical Senses: Past, Present, and Future

“…In particular, a young woman reported an acute onset of anosmia 3 weeks after the beginning of the first SARS-CoV specific symptoms (Hwang, 2006). This anosmia time course is compatible with the onset of SARS-CoVrelated peripheral neuropathy as described above (Tsai et al, 2004), suggesting that acute anosmia may occur due to coronavirus-related olfactory nerve damage. It is evident from this sparse information on olfactory function was not routinely examined by clinicians during the SARS-CoV outbreak.…”

A Remarkable Case of Acute Motor-Sensory Axonal Polyneuropathy (AMSAN) Variant of Guillain Barré Syndrome, in a Diabetic Patient Infected With COVID-19: A Case Report and Review of the Literature

“…So far, three cases have been documented in the literature, two with sphincter dysfunction and one with hypertension ( 23 ). However, there were no symptoms suggestive of autonomic system disturbance in our patient or the five cases reported from Italy ( 9 ). In addition to the conventional post-infectious pattern, numerous instances of GBS post-COVID-19 had followed a para-infectious course ( 24 ).…”

Frequency of Neurological Presentations of Coronavirus Disease in Patients Presenting to a Tertiary Care Hospital During the 2019 Coronavirus Disease Pandemic

“…In comparison, of 214 COVID-19 patients in Wuhan, China, 78 (36.4%) had neurologic manifestation, a much higher percentage [ 2 - 5 ]. Our study confirmed that headache (6%), altered level of consciousness and encephalopathy (2%), hemiparesis (stroke; 0.6%), GBS (0.3%) and seizure (0.3%) were the most frequently reported neurological presentations [ 5 , 6 , 7 , 8 ].…”

“…[2][3][4][5]. Our study confirmed that headache (6%), altered level of consciousness and encephalopathy (2%), hemiparesis (stroke; 0.6%), GBS (0.3%) and seizure (0.3%) were the most frequently reported neurological presentations [5,6,7,8].…”

Coronaviruses and the Chemical Senses: Past, Present, and Future

“…In particular, a young woman reported an acute onset of anosmia 3 weeks after the beginning of the first SARS-CoV specific symptoms (Hwang, 2006). This anosmia time course is compatible with the onset of SARS-CoVrelated peripheral neuropathy as described above (Tsai et al, 2004), suggesting that acute anosmia may occur due to coronavirus-related olfactory nerve damage. It is evident from this sparse information on olfactory function was not routinely examined by clinicians during the SARS-CoV outbreak.…”

A Remarkable Case of Acute Motor-Sensory Axonal Polyneuropathy (AMSAN) Variant of Guillain Barré Syndrome, in a Diabetic Patient Infected With COVID-19: A Case Report and Review of the Literature

“…So far, three cases have been documented in the literature, two with sphincter dysfunction and one with hypertension ( 23 ). However, there were no symptoms suggestive of autonomic system disturbance in our patient or the five cases reported from Italy ( 9 ). In addition to the conventional post-infectious pattern, numerous instances of GBS post-COVID-19 had followed a para-infectious course ( 24 ).…”

Frequency of Neurological Presentations of Coronavirus Disease in Patients Presenting to a Tertiary Care Hospital During the 2019 Coronavirus Disease Pandemic

“…In comparison, of 214 COVID-19 patients in Wuhan, China, 78 (36.4%) had neurologic manifestation, a much higher percentage [ 2 - 5 ]. Our study confirmed that headache (6%), altered level of consciousness and encephalopathy (2%), hemiparesis (stroke; 0.6%), GBS (0.3%) and seizure (0.3%) were the most frequently reported neurological presentations [ 5 , 6 , 7 , 8 ].…”

“…[2][3][4][5]. Our study confirmed that headache (6%), altered level of consciousness and encephalopathy (2%), hemiparesis (stroke; 0.6%), GBS (0.3%) and seizure (0.3%) were the most frequently reported neurological presentations [5,6,7,8].…”

Coronaviruses and the Chemical Senses: Past, Present, and Future

“…In particular, a young woman reported an acute onset of anosmia 3 weeks after the beginning of the first SARS-CoV specific symptoms (Hwang, 2006). This anosmia time course is compatible with the onset of SARS-CoVrelated peripheral neuropathy as described above (Tsai et al, 2004), suggesting that acute anosmia may occur due to coronavirus-related olfactory nerve damage. It is evident from this sparse information on olfactory function was not routinely examined by clinicians during the SARS-CoV outbreak.…”

A Remarkable Case of Acute Motor-Sensory Axonal Polyneuropathy (AMSAN) Variant of Guillain Barré Syndrome, in a Diabetic Patient Infected With COVID-19: A Case Report and Review of the Literature

“…So far, three cases have been documented in the literature, two with sphincter dysfunction and one with hypertension ( 23 ). However, there were no symptoms suggestive of autonomic system disturbance in our patient or the five cases reported from Italy ( 9 ). In addition to the conventional post-infectious pattern, numerous instances of GBS post-COVID-19 had followed a para-infectious course ( 24 ).…”